Clinical trials in Schweinfurt

Multiple innovative trials focusing on breast cancer treatment, particularly examining new therapeutic combinations for different subtypes including HR-positive, HER2-positive, and triple-negative breast cancer.

• Early-stage breast cancer interventions
• Neoadjuvant therapy approaches
• Targeted combination treatments

Studies are evaluating novel drug combinations with established treatments to improve patient outcomes.

Comprehensive research into colorectal cancer and gastroesophageal cancers, with trials exploring both metastatic and non-metastatic disease states.

• Advanced colorectal cancer treatments
• Preoperative therapy strategies
• Targeted immunotherapy approaches

Innovative combinations of immunotherapy and targeted agents are being tested to improve survival rates.

Groundbreaking research in ovarian cancer treatment, focusing on newly diagnosed advanced cases and maintenance therapy strategies.

• Advanced ovarian cancer protocols
• Combination therapy approaches
• Maintenance treatment strategies

Studies incorporate novel therapeutic combinations with standard treatments to enhance treatment efficacy.

Leading-edge research in non-small cell lung cancer, exploring innovative first-line treatments and targeted therapies.

• Metastatic lung cancer treatments
• Targeted molecular therapies
• Immunotherapy combinations

Focus on personalized treatment approaches based on specific genetic markers.